Simultaneous transcatheter pulmonary and tricuspid valve‐in‐valve implantation for the treatment of failing pulmonary and tricuspid bioprostheses

Baig, Muhammad; Alli, Oluseun; Davies, James E.

doi:10.1002/ccd.26332

Cited by 5 publications

(4 citation statements)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among all, one patient received two valves in the same procedure – that is, in the pulmonary and tricuspid positions. Until now, there has been only one publication of a double implant of Sapien XT valve in a patient during the same procedure 7 . Our patient is the first young adult patient with CHD in Europe to undergo a double implant in the same procedure.…”

mentioning

confidence: 88%

Edwards valve-in-valve implantation in tricuspid position

Álvarez-Fuente

Haas²,

Cerro

2017

Cardiol Young

View full text Add to dashboard Cite

We present two cases of percutaneous Sapien XT valve-in-valve implantation in the tricuspid position: a 20-year-old man with severe congenital pulmonary stenosis and percutaneous valvuloplasty, who required surgical implantation of two protheses, pulmonary and tricuspid, and a 12-year-old boy with CHD and a degenerated tricuspid prosthesis. We implanted three Sapien XT valve-in-valves, two in the tricuspid position and one in the pulmonic position. Sapien XT valve-in-valve implantation in the tricuspid position is feasible and can decrease the number of surgeries in CHD patients.

show abstract

mentioning

confidence: 88%

Edwards valve-in-valve implantation in tricuspid position

Álvarez-Fuente

Haas²,

Cerro

2017

Cardiol Young

View full text Add to dashboard Cite

show abstract

“…Schlomicher et al reported a simultaneous ViV procedure and TAVI for failed mitral and aortic positions with an uneventful postoperative course. Another case report by Baig et al reported a simultaneous transcatheter pulmonary and tricuspid ViV implantation for failed pulmonary and tricuspid bioprostheses in a 54‐year‐old man with multiple comorbidities.…”

Section: Discussionmentioning

confidence: 99%

“…The use of bioprosthetic valves has been on the rise the world over . However, failed surgical bioprostheses, particularly in terms of durability in younger individuals, have always been a concern for cardiologists and cardiac surgeons .…”

Section: Introductionmentioning

confidence: 99%

Single‐session double valve replacement: TAVI+tricuspid valve‐in‐valve procedures

et al. 2019

View full text Add to dashboard Cite

We describe a 70-year-old lady with rheumatic heart disease and a history of the mitral valve and tricuspid valve replacement, who underwent transcatheter aortic valve implantation and the tricuspid valve-in-valve procedure in a single session. K E Y W O R D S aorta, transcatheter valve implantation, transcatheter aortic valve implantation (TAVI), tricuspid, valve replacement, valve-in-valve (ViV)

show abstract

“…5 The risks of mortality and major morbidity are higher in the setting of redo sternotomy. 1,5 Combined transcatheter tricuspid valve replacement and pulmonary valve replacement (TTVR and TPVR, respectively) has been reported in patients with carcinoid heart disease 6,7 and congenital heart disease 8,9 whose cases were deemed to be high risk for operative intervention. Published data on combined TTVR/TPVR thus far have been limited to single case reports.…”

Section: Introductionmentioning

confidence: 99%

Combined Transcatheter Tricuspid and Pulmonary Valve Replacement

Small

Aksoy

Levi³

et al. 2020

World J Pediatr Congenit Heart Surg

View full text Add to dashboard Cite

Background: For patients with combined tricuspid and pulmonary valve disease, operative intervention carries high mortality risk. Published reports of combined transcatheter tricuspid and pulmonary valve replacement have been limited to single cases. Methods: A retrospective chart review was performed including all patients undergoing combined transcatheter tricuspid and pulmonary valve replacement at the Ahmanson/UCLA Adult Congenital Heart Disease Center. Results: Combined transcatheter tricuspid and pulmonary valve replacement was undertaken in five adult patients (median age: 46 years; range: 24-64 years). Three had congenital heart disease and two had carcinoid syndrome. Four patients had previous surgical tricuspid valve replacement and one had a surgical incomplete annuloplasty ring. Four patients had previous surgical pulmonary valve replacement and one had a right ventricle-to-pulmonary artery homograft conduit. Two patients underwent Medtronic Melody valve implantation in both tricuspid and pulmonary positions and three underwent Edwards Sapien S3 implantation in both tricuspid and pulmonary positions. Valve implantation was successful in all. Follow-up ranged from 0.9 to 3.0 years. One patient underwent redo transcatheter tricuspid valve replacement 12 months after the first transcatheter intervention for progressive regurgitation of a Melody valve. This patient died 2.5 years after combined valve placement of complications from refractory heart failure. The remaining patients were alive and free of valve reintervention at follow-up. Conclusions: Combined transcatheter tricuspid and pulmonary valve replacement can be performed successfully, with an acceptable complication rate. This strategy is a feasible option for appropriately selected patients.

show abstract

Simultaneous transcatheter pulmonary and tricuspid valve‐in‐valve implantation for the treatment of failing pulmonary and tricuspid bioprostheses

Cited by 5 publications

References 15 publications

Edwards valve-in-valve implantation in tricuspid position

Edwards valve-in-valve implantation in tricuspid position

Single‐session double valve replacement: TAVI+tricuspid valve‐in‐valve procedures

Combined Transcatheter Tricuspid and Pulmonary Valve Replacement

Contact Info

Product

Resources

About